Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook TranscriptSeeking Alpha • 12/08/25
Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/10/25
Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability GrowthGlobeNewsWire • 11/10/25
Countdown to Kamada (KMDA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 11/06/25
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025GlobeNewsWire • 11/03/25
Wall Street Analysts Believe Kamada (KMDA) Could Rally 113.15%: Here's is How to TradeZacks Investment Research • 10/30/25
Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect?Zacks Investment Research • 10/14/25
Wall Street Analysts See an 110.11% Upside in Kamada (KMDA): Can the Stock Really Move This High?Zacks Investment Research • 09/03/25
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPSZacks Investment Research • 08/08/25